SecBot SecBot
PRESS-RELEASE ·Filed May 20, 2026

DYN

Dyne Therapeutics, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed6mo ago WireGlobeNewswire
Press release · Activist
Actionable Insight • Neutral

No material event for traders. The grants are routine and do not change the company's outlook. Monitor Dyne's pipeline updates for DMD and DM1 for future catalysts.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$17.37
T+0 close · May 20, 2026 · via day close
Latest settled
+50.55%
T+60 · $26.15
Vs SPY
+46.25%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 21 $17.37entry
  2. T+1 · 6mo ago 0.00%α −0.45% · $17.37
  3. T+5 · 6mo ago +6.85%α +5.25% · $18.56
  4. T+20 · 5mo ago +20.15%α +19.82% · $20.87
  5. T+60 · 3mo ago +50.55%α +46.25% · $26.15
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Dyne Therapeutics granted inducement equity awards to 17 newly hired employees, consisting of stock options for 296,500 shares and RSUs for 94,100 shares, vesting over four years. This is a routine compensation action with no material financial impact.

Key Facts

  • Inducement grants to 17 new employees.
  • Stock options for 296,500 shares at closing price.
  • RSUs for 94,100 shares.
  • Both award types vest over four years.

Financial Impact

Minimal; equity grants are standard for new hires and do not reflect operational performance.

dilution

Risk Factors

  • No new risks identified from this filing.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
85% bullish (20 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3298933

Track record

54 reports on DYN

Performance horizon

12 of 16 bullish or bearish reports moved the stock their way by T+20. Best: +46.36% at T+60 after the May 20, 2026 report. 15 of 16 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G Neutral 3/10 Entry $16.77 Now $16.70 −0.39% settles Dec 15
  2. Nov 13, 20263d ago 144 Neutral 2/10 Entry $17.16 Now $16.70 −2.68% settles Dec 15
  3. Nov 13, 20263d ago 144 Neutral 2/10 Entry $17.16 Now $16.70 −2.68% settles Dec 15
  4. Nov 5, 202611d ago 8-K Neutral 5/10 No price data
  5. Nov 5, 202611d ago Press Release Neutral 5/10 Entry $17.36 Now $16.70 −3.80% settles Dec 4
  6. Oct 29, 202618d ago Institutional Cluster Neutral 2/10 Entry $17.04 Now $16.70 −2.00% settles Nov 27
  7. Oct 22, 202625d ago Press Release Neutral 2/10 Entry $15.62 Now $16.70 +6.91% settles Nov 20
  8. Oct 12, 20265w ago Institutional Cluster Mixed 4/10 Entry $15.96 to $18.62 Now $16.70 +4.64% ▲ +16.67% +19.93% vs SPY
  9. Sep 29, 20266w ago Press Release Bullish 7/10 Entry $16.11 to $16.94 Now $16.70 +3.66% ▲ +5.15% +4.23% vs SPY
  10. Sep 8, 20269w ago Insider Cluster Neutral 3/10 Entry $19.19 to $15.97 Now $16.70 −12.98% ▼ −16.78% −18.72% vs SPY
Showing 10 of 54

US Market Status

Market Closed · Opens Wed (10h 43m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 20, 2026